Open Access
Subscription Access
Use of Lycopene in the Management of Oral Submucous Fibrosis: A Clinical Study
Objective: The study was done to evaluate the efficacy of oral lycopene therapy when used in combination with conventional intralesional steroid therapy in the management of oral submucous fibrosis.
Methods: Thirty patients with oral submucous fibrosis (grade III and IV) were included and randomly divided into 2 groups consisting of 15 each: Group A (oral lycopene with biweekly intralesional steroids and hyaluronidase), Group B (biweekly intralesional steroids and hyaluronidase alone). Mouth opening and burning sensation were recorded from baseline to 6 weeks. Cases were followed up to 3 and 6 months.
Results: We observed a complete relief of burning sensation in all patients of both the groups, There was significant increase in mouth opening among both groups. The patients in the group B had increased moth opening than the group A patients.The results were statistically significant.
Conclusion: Lycopene in combination with intralesional steroids and Hyaluronidase, is highly efficacious in improving the mouth opening and reducing other symptoms in patients with Oral Submucous Fibrosis. No side effects were reported with its usage.
Keywords
- Akbar M. Oral submucous fibrosis - a clinical study. J Indian Dent Acad 1976;48:365-73.
- Revant H Chole, Shailesh M Gondivkar, Amol R Gadbail, Swati Balsaraf, Sudesh Chaudhary, Snehal V Dhore, et al. Review of drug treatment for oral submucous fibrosis. Oral Oncol 2012;48 393-8.
- Kumar A, Begawadi A, Keluskar V, Singh M. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:207-13.
- Singh M, Krishanappa R, Bagewadi A, Keluskar V. Efficacy of oral lycopene in the treatment of oral leukoplakia. Oral Oncol 2004;40:591-6.
- Chandra GDS, Rameshwar DS, Iqbal A.Treatment modalities in Oral submucous fibrosis: how they stand today? Study of 600 cases. Indian Journal of Oral and Maxillofacial surgery 1992;7:43-7.
- Teodoro AJ, Oliveira FL, Martins NB, Maia GA, Martucci RB, Borojevic R. Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Cancer Cell Int 2012 Aug6; 12(1):36.
- Palozza P, Catalano A, Simone R, Cittadini A. Lycopene as a guardian of redox signalling. Acta Biochim Pol 2012;59(1):21-5.
- Stahl W, Junghans A, De Boer B, Driomina ES, Briviba K, Sies H. Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett 1998;427:305-8.
- Ranganathan K, Devi Mu, Joshua E, Kirankumar K, Saraswathi TR. Oral submucous fibrosis: a case-control study in Chennai, South India. J Oral Pathol Med 2004;33(5):274-7.
- Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW. Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med 1994; 23(2):65-9.
- Bathi RJ, Parveen S, Burde K. The role of gutka chewing in oral submucous fibrosis: a case-control study. Quintessence Int 2009;40(6):e19-25.
- Heber D, Lu Q-Y. Overview of mechanisms of action of lycopene. Exp Biol Med 2002;227:920-3.
- PalozzaP, Parrone N, Catalano A, Simone R. Tomato lycopene and inflammatory cascade: basic interactions and clinical implications. Curr Med Chem 2010;17(23):2547-63.
- Kitade Y, Watanabe S, Masaki T, Nishioka M, Nishino H. Inhibition of liver fibrosis in LEC rats by a carotenoid, lycopene, or an herbal medicine, Shosaikoto. Hepatol Res 2002;22(3):196-205.
Abstract Views: 251
PDF Views: 155